Leading Edge Controversies: Whose Side are You On?

Sunday, April 7, 2024

4:00pm – 5:30pm

Location:400-402

CE: 1.5

In this session on leading-edge technologies, we will debate the benefits and concerns of gene therapy. Two professionals will start us off with their positions, and then the audience will be engaged for their views and input into this debate.

Moderator(s)

Helen Feltovich, MD (she/her/hers)

Obstetrician-Gynecologist
Icahn School of Medicine at Mount Sinai
New York, United States

Session Speaker(s)

LD

Laura Detti, MD

Professor of Ob-Gyn, Division and Fellowship Director, Reproductive Endocrinology and Infertility
Baylor College of Medicine, Houston, TX
LB

Laura Brattain, PhD

Associate Professor of Medicine
University of Central Florida
Orlando, United States
Michael Blaivas, MD, MBA

Professor of Medicine
University of South Carolina School of Medicine
Roswell, United States
Lawrence Platt, MD

Professor (Clinical) of OB/GYN
Ob Gyn David Geffen School of Medicine at UCLA
David Geffen School of Medicine at UCLA
Los Angeles, United States

Learning Objectives:

Demonstrate the ability to identify and address perceived risks and concerns related to AI.
Articulate the merits and positive impacts of AI
Facilitate constructive dialogue between proponents and critics of the new lexicon to describe the nonviable pregnancy in the post-Dobbs era

Presentations:

4:00pm – 4:45pm

Artificial Intelligence: Friend or Foe? Con Position
Michael Blaivas, MD, MBA – University of South Carolina School of Medicine
4:00pm – 4:45pm

Artificial Intelligence: Friend or Foe? Pro Position
Laura Brattain, PhD – University of Central Florida
4:45pm – 5:30pm

Nonviable Pregnancy: Change the Lexicon or Let it Be? Con Position
Lawrence D. Platt, MD – David Geffen School of Medicine at UCLA
4:45pm – 5:30pm

Nonviable Pregnancy: Change the Lexicon or Let it Be? Pro Position
Laura Detti, MD – Baylor College of Medicine, Houston, TX